Aug 29, 2023 08:01AM
Aug 29, 2023 08:00AM
Aug 3, 2023 07:30AM
May 4, 2023 04:47PM
May 4, 2023 04:30PM
Apr 17, 2023 08:01AM
Apr 17, 2023 08:00AM Axcella Announces Two Oral Presentations on AXA1125 for Long COVID Fatigue at ECCMID 2023
Mar 30, 2023 08:07AM
Mar 30, 2023 08:00AM
Feb 15, 2023 04:13PM
Feb 15, 2023 04:10PM
Jan 23, 2023 04:15PM
Jan 23, 2023 04:15PM
Dec 14, 2022 08:01PM Axcella Announces Program Reprioritization and Corporate Restructuring
Nov 1, 2022 07:00AM
Oct 27, 2022 08:30AM
Oct 13, 2022 08:03AM
Oct 13, 2022 08:00AM
Sep 29, 2022 06:11AM
Sep 29, 2022 06:00AM
Aug 12, 2022 07:30AM Axcella Reports Second Quarter Financial Results and Provides Business Update
Aug 2, 2022 06:00AM
May 26, 2022 07:00AM
May 5, 2022 07:00AM
Mar 30, 2022 07:35AM
Mar 30, 2022 07:32AM
Mar 30, 2022 07:32AM
Mar 23, 2022 07:02AM Axcella to Report Fourth Quarter and Year End 2021 Financial Results on March 30, 2022
Feb 14, 2022 07:58AM
Feb 14, 2022 07:58AM
Feb 7, 2022 07:55AM
Feb 7, 2022 07:55AM
Jan 6, 2022 07:58AM
Jan 6, 2022 07:58AM
Dec 16, 2021 07:28AM Axcella Therapeutics Announces Initiation of AXA1125 Long COVID Phase 2a Clinical Trial
Dec 6, 2021 07:50AM
Dec 6, 2021 07:50AM
Nov 10, 2021 07:59AM
Nov 10, 2021 07:58AM
Oct 26, 2021 06:58AM
Oct 26, 2021 06:58AM
Oct 19, 2021 07:58AM Axcella, Now Axcella Therapeutics, to Host Virtual R&D Day on October 26, 2021
Aug 16, 2021 07:59AM
Aug 16, 2021 07:58AM
Jul 29, 2021 07:38AM
Jul 29, 2021 07:28AM
Jul 22, 2021 07:28AM
Jun 30, 2021 07:28AM
May 24, 2021 07:28AM Axcella Health (AXLA) Announces Positive Clinical Data About AXA1665 Candidate for Overt Hepatic Encephalopathy Highlighted in Oral Presentation at DDW 2021
May 24, 2021 07:28AM

1,197,296 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All